| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | — | -36.6% |
| Cost of Revenue | $1.1M | — | -32.0% |
| Gross Profit | $1.1M | — | -40.5% |
| R&D Expense | $583K | — | -41.0% |
| SG&A Expense | $4.1M | — | +59.1% |
| Operating Income | -$5.6M | — | -63.3% |
| Net Income | -$6.9M | — | -138.2% |
| EPS (Basic) | -$2.04 | — | -1600.0% |
| EPS (Diluted) | -$2.04 | — | -1600.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.0M | +241.6% | -50.4% |
| Accounts Receivable | $4.5M | -37.9% | -29.7% |
| Inventory | $4.6M | -3.6% | -6.3% |
| Current Assets | $14.1M | +0.0% | -30.0% |
| Total Assets | $19.7M | -2.2% | -28.0% |
| Current Liabilities | $9.1M | +5.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.1M | — | -8.0% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | $0 | — | +100.0% |
| Financing Cash Flow | $5.0M | — | +40.3% |
| Free Cash Flow | -$2.1M | — | -7.5% |
| +6.3% |
| Total Liabilities | $13.9M | +25.7% | -4.7% |
| Stockholders' Equity | $2.1M | -76.8% | -83.5% |